NIH director says there is no need for booster shots yet
NIH Director Dr. Francis Collins says Pfizer may be getting ahead of itself in applying for emergency use authorization for a booster dose of its COVID-19 vaccine.
NIH Director Dr. Francis Collins says Pfizer may be getting ahead of itself in applying for emergency use authorization for a booster dose of its COVID-19 vaccine.
More than six million Americans are living with Alzheimer’s, but there is new hope for those in the earliest stages of the disease. We’re learning more about the new treatment approved by the FDA.
Vaccine advisers from the Food and Drug Administration met this week to discuss the risks and benefits of COVID-19 shots for kids.
Government health officials have approved the first drug that they say may help slow Alzheimer’s disease.
Consumer News: Family Dollar to start selling fresh groceries, FDA warns those with seafood allergies not to eat cicadas and more.
The FDA is expanding the emergency use authorization for the Pfizer vaccine for kids ages 12-15. CDC leaders plan to meet later this week to discuss distribution, and kids could start getting shots in arms as early as this week once the CDC director signs the agency’s recommendations.
This week, the Food and Drug Administration is expected to grant emergency use authorization of Pfizer’s COVID-19 vaccine for kids between 12-15 years old.
The FDA says about four in five U.S. adults consume caffeine every day, but it’s important to know how much is too much and to know when to stop, so your sleep isn’t affected.
The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for kids ages 12 to 15 by next week, setting up shots for many before the beginning of the next school year.
The Food and Drug Administration is taking steps to ban menthol flavored cigarettes and all flavored cigars within the next year. Ultimately, the goal is to reduce disease and death from those products.